✦ LIBER ✦

Health-Related Quality of Life (HRQOL) in End Stage Renal Disease (ESRD) patients over 65 years

✍ Scribed by Pablo Rebollo; Francisco Ortega; Jose M. Baltar; Carmen Díaz-Corte; Rafael A Navascués; Manuel Naves; Ana Ureña; Xavier Badía; Fernando Alvarez-Ude; Jaime Alvarez-Grande

Book ID: 110262395
Publisher: Springer
Year: 1998
Tongue: English
Weight: 74 KB
Volume: 8
Category: Article
ISSN: 0924-8455
DOI: 10.1023/a:1008338802209

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pediatric end stage renal disease health

Pediatric end stage renal disease health-related quality of life differs by modality: a PedsQL ESRD analysis

✍ Stuart L. Goldstein; Nicole M. Rosburg; Bradley A. Warady; Mouin Seikaly; Ruth M 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 137 KB

New trends on health related quality of

New trends on health related quality of life assessment in end-stage renal disease patients

✍ Pablo Rebollo; Francisco Ortega 📂 Article 📅 2002 🏛 Springer Netherlands 🌐 English ⚖ 88 KB

Health related quality of life in patien

✍ G. J. Zimmerman; L. L. D’Antonio; R. P. Iacono 📂 Article 📅 2004 🏛 Springer Vienna 🌐 English ⚖ 126 KB

Long-term, health-related, quality of li

Long-term, health-related, quality of life comparison in patients undergoing single stage vs staged resection for complicated diverticular disease

✍ V. A. Constantinides; H. N. Aydin; P. P. Tekkis; V. W. Fazio; A. G. Heriot; F. H 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

Quality of life of end-stage renal disea

Quality of life of end-stage renal disease patients and study on the implementation of nocturnal home hemodialysis in Greece

✍ Kallirroi STAVRIANOU; Nicolas PALLIKARAKIS 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Sustained improvement of health-related

Sustained improvement of health-related quality of life in Crohn's disease patients treated with infliximab and azathioprine for 4 years

✍ Francesc Casellas; Luis Rodrigo; Pilar Niño; Carmen Pantiga; Sabino Riestra; Jua 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views

## Background: Infliximab induces remission and improves the health-related quality of life (hrqol) of patients with refractory or fistulous crohn's disease (cd). however, little information is available as to whether its effect on hrqol is sustained over time. the objective was to measure the hrqo